+27.9%
DVN vs THC
+237.8%
-209.9%
-60.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -0.2% | -1.1% | -1.2% |
| 7D | -10.8% | -8.0% | -2.8% | -9.7% |
| 30D | -16.7% | -2.2% | -14.5% | -16.6% |
| 3M | -15.2% | -3.5% | -11.7% | -15.0% |
| 6M | -13.1% | +40.4% | -53.5% | -19.4% |
| YTD | +15.6% | +32.4% | -16.9% | +7.2% |
| 1Y | +21.2% | +41.0% | -19.8% | +10.6% |
| 3Y | +0.4% | +305.2% | -304.8% | -32.3% |
| All | +27.9% | +237.8% | -209.9% | -10.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling